Evoke Wealth, LLC Organon & Co. Transaction History

Evoke Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$23.4 - $34.25 $3,252 - $4,760	-139 Reduced 37.17%	235 $5,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $4,907 - $6,029	-155 Reduced 29.3%	374 $13,000
Q1 2022 May 10, 2022	BUY	$30.45 - $39.36 $365 - $472	12 Added 2.32%	529 $18,000
Q4 2021 Feb 09, 2022	BUY	$28.67 - $37.13 $28 - $37	1 Added 0.19%	517 $16,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $6,355 - $7,912	-222 Reduced 30.08%	516 $16,000
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $20,996 - $28,044	738 New	738 $19,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.